KFG
FOLD

Kingdom Financial Group’s Amicus Therapeutics FOLD Stock Holding History

Kingdom Financial Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,327
Closed -$164K – 885
2026
Q1 		$164K Sell
11,327
-3,718
-25% -$53.3K 0.05% 164
2025
Q4 		$214K Buy
+15,045
New +$148K 0.07% 145

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Kingdom Financial Group's FOLD Position: Q2 2026 in Review

Kingdom Financial Group sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 11,327 shares — an estimated $164K sold.

Kingdom Financial Group first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $214K in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Kingdom Financial Group reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Kingdom Financial Group sold 11,327 Amicus Therapeutics shares in Q2 2026, an estimated $164K.
  • Kingdom Financial Group first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
  • Kingdom Financial Group's Amicus Therapeutics position peaked at $214K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Kingdom Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.